For almost 80 years, the Endocrine Society has recognized the meritorious achievements of endocrine researchers and clinicians worldwide. These Laureate Awards recognize endocrinologists for seminal research, meritorious service, leadership and mentorship, innovation, international contributions, public service, translation of science to practice, and lifetime achievement. The Society presented the awards at ENDO 2022, the Society’s annual meeting. For information on nominating a deserving endocrinologist, and to learn more about these awards, please visit our Laureate Awards nomination page.
The Endocrine Society’s 2022 Laureate Award winners are:
The Society’s highest honor, this annual award recognizes lifetime achievements and exceptional contributions to the field of endocrinology. Kronenberg has been Chief of the Endocrine Unit at Massachusetts General Hospital for over 32 years and is a Professor of Medicine at Harvard Medical School in Boston, Mass. His research group studies the actions of parathyroid hormone and parathyroid hormone-related protein, with a particular emphasis on bone development, bone biology, calcium homeostasis, and the roles of osteoblast-lineage cells in hematopoiesis. His biggest accomplishment is bringing molecular biology to the bone and mineral field with the cloning of the parathyroid hormone. Kronenberg was President of the Endocrine Society in 2016-2017 and has served on many other Society Committees over the years, most notably as Vice President, Basic Science and as the Endocrine Society's representative on the FASEB Board of Directors.
This annual award recognizes outstanding contributions to research that accelerate the transition of scientific discoveries into clinical applications. Smith is the Frederick G.L. Huetwell Professor in Ophthalmology and Visual Sciences and Professor of Internal Medicine at the University of Michigan Medical School in Ann Arbor, Mich. With expertise in the study of Graves’ disease, its ocular manifestations, and related autoimmune diseases, Smith’s lab was the first to describe the unique molecular attributes of tissue surrounding the eye that make the orbit susceptible to immune activation and inflammation in Graves’ disease. He and his colleagues have mapped mechanisms involved in tissue remodeling occurring in thyroid-associated ophthalmopathy (TAO), a disfiguring and potentially blinding disease. They identified the insulin-like growth factor-I receptor as a therapeutic target for TAO and their work has culminated in the creation of teprotumumab—the first FDA approved drug to treat thyroid eye disease.
This award is presented to an endocrinologist who has made exceptional contributions to the field in geographic areas with underdeveloped resources for hormone health research, education, clinical practice, or administration. Ibáñez is a pediatric endocrinologist at Sant Joan de Déu Barcelona Hospital and Chairman of Pediatrics, Chair of Clinical Research in Endocrinology at the University of Barcelona in Barcelona, Spain. She’s a worldwide leader in the field of PCOS who pioneered the use of combined, low-dose insulin sensitization for the treatment of the disease - a novel therapeutic approach directed to the pathophysiology of the disorder. Ibáñez started the Fellowship Program in Pediatric Endocrinology & Diabetes of the University of Barcelona back in 2002 and has mentored 22 fellows from Latin America.
This annual award honors an internationally recognized clinical investigator who has contributed significantly to understanding the pathogenesis and therapy of endocrine and metabolic diseases. Pacak is Chief of the Section on Medical Neuroendocrinology and Head of the Developmental Endocrinology, Metabolism, Genetics and Endocrine Oncology Affinity Group of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the Intramural NIH Research Program in Bethesda, M.d. An extraordinary clinician whose translational research has provided novel understanding of and treatments for patients with neuroendocrine tumors, especially pheochromocytoma and paraganglioma, Pacak established the International Symposia on Pheochromocytoma, the most internationally recognized meeting in this field. He was part of the Endocrine Society’s 2014 Pheochromocytoma Task Force and currently serves as a member of The Journal of Clinical Endocrinology & Metabolism’s Editorial Board.
This annual award recognizes extraordinary contributions by a practicing endocrinologist to the endocrine and/or medical community. Harris is a full-time practicing endocrinologist at the Warren Clinic Diabetes Center in Tulsa, Okla., where he’s provided exemplary care for over 30 years. He’s a tireless advocate for equal access to care and affordable diabetes medications. He led the glycemic management committee at Saint Francis Hospital to ensure consistent treatment protocols for hospitalized patients. Harris has been instrumental in providing scholarships for medical and high school students in need. He’s a member of the Endocrine Society’s Hormone Health Network Committee and previously served on the Scientific and Educational Programs Core Committee.
This annual award recognizes exceptional achievement as an educator in the discipline of endocrinology and metabolism. Martin, an Assistant Professor of Medicine at Harvard Medical School, has been a faculty member and practicing clinician in the Reproductive Endocrine Unit at Massachusetts General Hospital in Boston, Mass., since 1989. Martin is an outstanding clinician and teacher with a remarkable skill at synthesizing even the most complex clinical and basic literature. In her active teaching role, she is involved in the training and supervision of junior faculty members and endocrine fellows. Martin is an internationally recognized authority in women’s health who’s contributed significantly to the field’s current status as a data driven medical science. She’s contributed to several Endocrine Society Clinical Practice Guidelines and Scientific Statements on women’s health.
This annual award recognizes outstanding leadership in fundamental or clinical endocrinology. Wass is a highly accomplished clinical researcher and educator at Oxford University in Oxford, England. His contributions have had a significant effect on patients with pituitary disease. His early observations about the importance of single-surgeon expertise for acromegaly outcomes paved the way many years later for adoption of criteria for pituitary centers of excellence, while his early recognition of the need to minimize neurological sequelae in pituitary apoplexy paved the way for studies – still ongoing – to establish best practices for this difficult-to-manage disorder. In these areas, as well as in PCOS, Addison’s disease and obesity, Wass’s leadership has enabled endocrinologists to adopt new approaches to improve patient outcomes. He has trained multiple endocrinologists who are well recognized globally for their own leading contributions to endocrinology research and practice.
This annual award recognizes a career commitment to mentoring and a significant positive impact on mentees’ education and career. Reusch is a Professor of Medicine and Biochemistry at the University of Colorado Denver and Denver VAMC and Associate Director of the Center for Women’s Health Research in Aurora, Colo. She has mentored 77 trainees through her research program ranging from students to senior faculty. At the University of Colorado, Reusch continues to actively mentor pre- and post-doctoral fellows and directs the University of Colorado Pilot and Feasibility Program to fund diabetes researchers. Reusch represented the Endocrine Society as chair of the FASEB Science Policy Clinical Research sub-committee focused on career development.
This annual award is presented to an individual who best demonstrates dedication to public awareness or public service in support of the field of endocrinology, and the patients who suffer from endocrine disorders. Kalyani is an Associate Professor of Medicine in the Division of Endocrinology, Diabetes & Metabolism at Johns Hopkins University School of Medicine in Baltimore, Md. She is a clinician-scientist who has led statewide public awareness initiatives, chaired national clinical practice guideline committees, and spearheaded the development of international programs for diabetes care. She participated in Endocrine Society Hill Days and served as a Society spokesperson on insulin affordability. Kalyani currently serves on multiple Endocrine Society committees, including the Clinical Practice Guideline Task Force and the EndoCares Steering Team. She was previously a member of the Society’s Research Affairs Core Committee.
NOTE: This award has been retired. Nominations will no longer accepted for this award.
This annual award recognizes outstanding contributions to the practice of clinical endocrinology in academic settings. Professor Ho is Emeritus Professor at the Garvan Institute, University of New South Wales and Honorary Consultant Endocrinologist, St. Vincent’s Hospital in Sydney, Australia. As a globally recognized pituitary medicine expert and a leader in academic clinical endocrinology, he’s developed therapeutic guidelines and advocated for regulatory agency decisions geared toward improving patient outcomes. He established a gold-standard diagnostic test for growth hormone (GH) deficiency and developed standards for use of GH replacement therapy in adults. He’s published over 250 peer-reviewed studies that directly impact clinical practice. He currently serves as Associate Editor for the Journal of the Endocrine Society and as a member of the Society’s Nominating Committee.
This annual award recognizes an exceptionally promising young clinical or basic investigator. As an investigator at Beth Israel Deaconess Medical Center in Boston Mass., Kajimura has made pioneering contributions to the field of endocrinology and metabolism by identifying the key determinants of adipose tissue development and function. Kajimura's work transformed our fundamental understandings of how brown/beige fat controls energy homeostasis in physiology and disease and further provides a blueprint for rewiring adaptive pathways to improve metabolic health. His studies led to the new but now well-appreciated notion that the role of brown/beige fat is far beyond thermogenesis. His discoveries have the potential to influence new therapies for diseases including obesity, NASH and type 2 diabetes. He’s currently a member of the Endocrine Society’s Basic Science Strategy Advisory Group.
This annual award recognizes meritorious contributions to research in endocrinology. Schwartz holds the Robert H. Williams Chair in Medicine at the University of Washington in Seattle, Wash. where he has been on faculty since 1996. He’s published over 260 peer-reviewed studies that have shaped our understanding of how the brain regulates energy balance and glucose homeostasis. His work investigating the central actions of leptin on energy balance and glucose metabolism over the last two decades has provided a novel avenue for developing weight-loss therapeutics. His lab currently focuses on the anti-diabetic effects of members of the FGF family, including FGF19, FGF21 and FGF1. A key long-term goal of these studies is to translate the findings into novel approaches for treating T2D.
This award recognizes distinguished service to the Endocrine Society and the field of endocrinology. Rhodes was appointed as the Provost and Vice President for Academic Affairs at the University of North Florida in Jacksonville, Fla. in 2019. Over the last 15 years, Rhodes has reached trainees and early career investigators around the world and given special attention to diversity, equity, and inclusion. He’s been engaged in the Endocrine Society’s FLARE program since its inception and served as a program presenter and mentor for eight years. He was also co-chair of the Endocrine Society’s Trainee and Career Development Core Committee and a member of the Minority Affairs Committee. He currently serves on the Society’s Finance & Audit Committee and the Global Leadership Academy Planning & Advisory Task Force.
Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.